Participant Sponsored Observational Study

Cancer Wellness Center of the Pacific is Now Recruiting Immune12 users for our Participant Sponsored study!
The Cancer Wellness Clinic of the Pacific is now offering Hope to GBM patients around the world with our all-natural, zero side effect product Immune12.
Observational studies and clinical trials are both essential components of medical research, but they differ significantly in their design, purpose, and methodology. Here’s how they compare:
Virtual Observational Studies
Glioblastoma Multiforme (GBM) is one of the most aggressive and challenging brain tumors to treat due to:
Tumor Heterogeneity
GBM tumors are highly heterogeneous, meaning they contain a diverse mix of cells with different genetic mutations. This makes it difficult for a single treatment to be effective against all tumor cells.
Glioma Stem Cells
GBM contains stem-like cells that can self-renew and are highly resistant to conventional therapies. These cells can repopulate the tumor even after aggressive treatment.
Blood-Brain Barrier
The blood-brain barrier protects the brain from harmful substances but also prevents many drugs from reaching the tumor effectively.
Tumor Microenvironment
GBM creates a highly immunosuppressive microenvironment that hinders the effectiveness of immunotherapies.
Recurrence
Even after aggressive treatment, GBM often recurs. The recurrent tumors are usually more resistant to treatment and more aggressive.
Current Standard of Care (SOC) treatment
The current SOC includes surgery, radiation and chemo which can offer GBM patients an average of 12-18 months of life post diagnosis. Anecdotal data offered by GBM survivors who have taken Immune12, either alone or with SOC treatments, has shown
- A prolonged life-span post-diagnosis, well beyond the 12-18 months.
- MRI’s showing tumor significant shrinkage even down to zero visible tumor on MRI and PET scans.
Immune12 is a Marine sourced Complex Biologic. Unlike current conventional drugs, which are smaller molecules, that are synthesized chemically, with a structure that is well-defined and simpler than biologics. Due to their complexity and the sophisticated technology required for their production, biologics represent more of a challenge to both manufacture and research.
Why Participate? The Positive Aspects of our Study.
The Cancer Wellness Clinic of the Pacific’s glioblastoma participant-sponsored remote observational study offers several positive aspects for participants. Overall, our participant-sponsored remote observational study enhances the efficiency, inclusivity, and patient-centricity of GBM research.
Cutting Edge
We are now beginning to see more patient-sponsored studies taking place around the world related to Neuro based diseases such as Multiple Sclerosis and Parkinson's disease, financed either entirely or partly by their participants. Our GBM focused observational study will be the first of its kind.
Empowerment
Participants will take an active role in their healthcare, which will lead to increased engagement and satisfaction.
Accessibility
Our study can include participants from diverse geographic locations, including those in remote or underserved areas, making the research more inclusive.
Convenience & Cost-Efficiency
Participants can join from their homes, reducing the need for travel and making it easier for those with mobility issues or busy schedules.
Real-Time Data Collection
Internet technologies enable real-time data collection, improving the accuracy and reliability of the data.
Faster Recruitment and Retention
The convenience and accessibility of our remote study will lead to quicker recruitment and higher retention rates, speeding up the research process for this much needed treatment.
Client-Centric Approach
These studies will focus on the participant’s experience, leading to higher satisfaction and better adherence to the study protocol.
Hastened Pathway to Market
Results from our study can lead to more rigorous clinical trials, government regulatory agency approvals, and thus faster consumer availability.
Low Financial Risk
The CWC provides a money back guarantee for Immune12 used in this study.